E-LIB Suche - Ergebnisse für: García-Cabeza, I.

1

Adherence, insight and disability in paranoid schizophrenia:

García-Cabeza, I. ; Díaz-Caneja, C.M. ; Ovejero, M..
Psychiatry Research. 270 (2018) - p. 274-280 , 2018

Link: https://doi.org/10.1016/..

2

P.3.d.012 One year of experience with paliperidone palmitat..:

García-Cabeza, I. ; De Diego, H. ; Pérez-Marín, P.
European Neuropsychopharmacology. 24 (2014) - p. S528 , 2014

Link: https://doi.org/10.1016/..

3

P.3.e.00l Initial motivation predicts long-term adherence t..:

García-Cabeza, I. ; Olmeda, M.S. ; Salgado, M.
European Neuropsychopharmacology. 19 (2009) - p. S567-S568 , 2009

Link: https://doi.org/10.1016/..

4

P.3.e.008 Treatment adherence in first psychotics episodes:

García-Cabeza, I. ; Gonz´alez de Ch´avez, M.
European Neuropsychopharmacology. 17 (2007) - p. S491 , 2007

Link: https://doi.org/10.1016/..

5

Predictors of number and severity of violence episodes in a..:

Bobes, J. ; Bombin, I. ; Gonzalez-Salvador, M.T...
Schizophrenia Research. 60 (2003) 1 - p. 333 , 2003

Link: https://doi.org/10.1016/..

6

PMH10: SUBJECTIVE RESPONSE TO ANTIPSYCHOTIC TREATMENT AND C..:

Garcia-Cabeza, I ; Gomez, JC ; Sacristan, JA...
Value in Health. 3 (2000) 5 - p. 346-347 , 2000

Link: https://doi.org/10.1016/..

7

Drug attitude inventory, spanish-adapted version:

García Cabeza, I. ; Hormaechea Beldarrain, J.A. ; Sanz Amador, M...
European Neuropsychopharmacology. 10 (2000) - p. 298-299 , 2000

Link: https://doi.org/10.1016/..

8

Subjective response to antipsychotics in schizophrenic pati..:

Garcı́a Cabeza, I. ; Sanz Amador, M. ; Arango López, C..
Schizophrenia Research. 41 (2000) 2 - p. 349-355 , 2000

Link: https://doi.org/10.1016/..

9

Comparison of the subjective response to typical neurolepti..:

Hormaechea, J.A. ; García Cabeza, I. ; Sanz, M...
European Neuropsychopharmacology. 8 (1998) - p. S238 , 1998

Link: https://doi.org/10.1016/..

10

P.2.102 Practical recommendations for the use of risperidon:

Gonzalez de Chavez, M. ; Sanz, M. ; García Cabeza, I...
European Neuropsychopharmacology. 7 (1997) - p. S224 , 1997

Link: https://doi.org/10.1016/..

11

Duration of untreated psychosis and its correlates in first..:

Kalla, O. ; Aaltonen, J. ; Wahl‐ström, J....
Acta Psychiatrica Scandinavica. 106 (2002) 4 - p. 265-275 , 2002

Link: https://doi.org/10.1034/..

12

Predictive factors of therapeutic compliance in schizophren..:

Díaz, E.I.Sánchez ; Cabeza, I.Garcia ; Gutiérrez, M..
European Neuropsychopharmacology. 8 (1998) - p. S211 , 1998

Link: https://doi.org/10.1016/..

13

P1837 Three years of universal molecular epidemiology of tu..:

Martínez, M. ; García de Viedma, D. ; Sánchez, M....
International Journal of Antimicrobial Agents. 29 (2007) - p. S525-S526 , 2007

Link: https://doi.org/10.1016/..

14

Clinical outcomes and mortality in patients with atrial fib..:

Piserra López-Fernández De Heredia, Alberto ; Ruiz Ortiz, Martín ; Pérez Cabeza, Alejandro I....
Current Problems in Cardiology. 49 (2024) 2 - p. 102239 , 2024

Link: https://doi.org/10.1016/..

15

A new mutation in the ACTA1 gene possibly associated with d..:

Díaz Expósito, Arancha ; Robles Mezcua, Ainhoa ; Pérez Cabeza, Alejandro I..
Revista Española de Cardiología (English Edition). 75 (2022) 10 - p. 850-852 , 2022

Link: https://doi.org/10.1016/..